487 Results

People

  1. De Angelis
    De Angelis
  2. Abrey
    Abrey
  3. Kelsen
    Kelsen
  4. Lichtman
    Lichtman
  5. Bajorin
    Bajorin
  6. Perales
    Perales
  7. Yahalom
    Yahalom
  8. Saltz
    Saltz
  9. Seidman
    Seidman
  10. Correa
    Correa

Groups

  1. Department of Medicine (257)
  2. Solid Tumor Oncology Division (171)
  3. Hematologic Malignancies, Division of (102)
  4. Center for Hematologic Malignancies (89)
  5. Survivorship Research (72)
  6. Tow Center for Developmental Oncology (TCDO) (51)
  7. Gastrointestinal Oncology Service (50)
  8. Surgery (45)
  9. Genitourinary Oncology Service (42)
  10. Bone Marrow Transplant (38)
  1. "neurotoxicity"
Formats
  1. Journal Article (426)
  2. Review (34)
  3. Editorial (6)
  4. Conference Paper (5)
  5. Book Section (4)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Meeting Abstract (2)
  9. Research Letter (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (257)
  2. Solid Tumor Oncology Division (171)
  3. Hematologic Malignancies, Division of (102)
  4. Center for Hematologic Malignancies (89)
  5. Survivorship Research (72)
  6. Tow Center for Developmental Oncology (TCDO) (51)

More Groups

People
  1. Lisa De Angelis (44)
  2. Lauren Abrey (29)
  3. David Kelsen (19)
  4. Stuart Lichtman (18)
  5. Dean Bajorin (17)
  6. Joachim Yahalom (17)

More People

Years
  1. 2025 (25)
  2. 2024 (26)
  3. 2023 (18)
  4. 2022 (10)
  5. 2021 (5)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (46)
  2. Cancer (19)
  3. Seminars in Oncology (15)
  4. Gynecologic Oncology (13)
  5. Journal of Neuro-Oncology (13)
  6. Blood (11)

More Publications

Publishers
  1. Elsevier Inc. (80)
  2. American Society of Clinical Oncology (47)
  3. Springer (41)
  4. Nature Publishing Group (28)
  5. Wiley Blackwell (27)
  6. Lippincott Williams & Wilkins (26)

More Publishers

Results (487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
    Journal Article

    King, A. C.; Pappacena, J. J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: A randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
    Journal Article

    Bolaños-Meade, J.; Reshef, R.; Fraser, R.; Fei, M.; Abhyankar, S.; Al-Kadhimi, Z.; Alousi, A. M.; Antin, J. H.; Arai, S.; Bickett, K.; more...
    The Lancet Haematology (2019)

    Fulltext@MSK | Save
  • Management of the critically ill adult chimeric antigen receptor-t cell therapy patient: A critical care perspective
    Journal Article

    Gutierrez, C.; McEvoy, C.; Mead, E.; Stephens, R. S.; Munshi, L.; Detsky, M. E.; Pastores, S. M.; Nates, J. L.
    Critical Care Medicine (2018)

    Fulltext@MSK | Save
  • Updates on primary central nervous system lymphoma
    Journal Article

    Schaff, L. R.; Grommes, C.
    Current Oncology Reports (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia
    Journal Article

    Park, J. H.; Rivière, I.; Gonen, M.; Wang, X.; Sénéchal, B.; Curran, K. J.; Sauter, C.; Wang, Y.; Santomasso, B.; Mead, E.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies
    Journal Article

    Kiesgen, S.; Chicaybam, L.; Chintala, N. K.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Primary central nervous system lymphoma
    Book Section

    de la Fuente, M. I.; Deangelis, L. M.
    In Raghavan, D.; Ahluwalia, M. S.; Blanke, C. D.; Brown, J. D.; Kim, E. S.; Reaman, G. H.; Sekeres, M. A. (Eds.) Textbook of Uncommon Cancer. 5th ed (2017)

    Fulltext@MSK | Save
  • Radiobiology and radiotherapy of brain metastases
    Journal Article

    Thiagarajan, A.; Yamada, Y.
    Clinical and Experimental Metastasis (2017)

    Fulltext@MSK | Save
  • Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: A pilot study
    Journal Article

    Correa, D. D.; Root, J. C.; Kryza-Lacombe, M.; Mehta, M.; Karimi, S.; Hensley, M. L.; Relkin, N.
    Brain Imaging and Behavior (2017)

    Fulltext@MSK | Save
  • Emerging role of CAR T cells in non-Hodgkin's lymphoma
    Journal Article

    Avanzi, M. P.; Brentjens, R. J.
    Journal of the National Comprehensive Cancer Network (2017)

    Fulltext@MSK | Save